Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2008, Vol. 13 ›› Issue (8): 909-912.

Previous Articles     Next Articles

Effects of polymorphisms of aldehyde dehydrogenase 2 gene on pharmacokinetic characteristics of isosorbide-5-mononitrate extended action tablet in Chinese healthy subjects

DU Shu-xian, LIU Yu-qing, TIAN Lei, LIU Hong, XIE Shuang, JlANG Juan-juan, WANG Ping, HUA Cong-xiao, LI Yi-shi   

  1. Key Laboratory of Clinical Trial Research in Cardiovascular Drugs Ministry of Health, FuwaICardiovascular Hospital, Peking Union Medical College and Chinese Academy of Medical Science, Beijing 100037, China
  • Received:2007-12-13 Revised:2008-05-26 Online:2008-08-26 Published:2020-10-12

Abstract: AIM:To investigate the effects of polymorphisms of aldehyde dehydrogenase 2 gene(ALDH2)at positions Glu504Lys on pharmacokinetic(PK)characteristics of isosorbide-5-mononitrate (IS-5-MN)in Chinese healthy volunteers.METHODS:Among 45 persons, twenty-two healthy male volunteers were selected and orally taken 60 mg IS-5-MN.An HPLC-MS method was applied to analyze IS-5-MN plasma concentration.ALDH2 genotype was determined by PCRRFLP.Pharmacokinetic analysis was performed to assess the effects of the genotype on IS-5-MN pharmacokinetics.RESULTS:In these 22 volunteers, 13 homozygous Gg and 9 heterozygous GA genotypes for ALDH2 at positions of Glu504Lys were detected by PCRRFLP.IS-5-MN plasma concentration, AUC0-t, Cmax and tmax did not show significant statistical difference (P>0.05)in the two groups.CONCLUSION:The polymorphisms of ALDH2 gene at positions of Glu504Lys could not influence the pharmacokinetics of IS-5-MN in the research.

Key words: isosorbide-5-mononitrate, aldehyde dehydrogenase 2, genetic polymorphism, pharmacokinetics

CLC Number: